ACAD — ACADIA PHARMACEUTICALS INC

Ownership history in OMERS ADMINISTRATION Corp  ·  3 quarters on record

This page tracks every 13F SEC filing in which OMERS ADMINISTRATION Corp reported a position in ACADIA PHARMACEUTICALS INC (ACAD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2016 Q3)
Avg. % of fund
0.02%
First filed
2016 Q2
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 28,600 -63,800 -69.0% 0.00% $610K $21.34
2016 Q3 ADDED 92,400 +84,800 +1115.8% 0.05% $2.9M $31.81
2016 Q2 INITIATED 7,600 — — 0.01% $247K $32.46
% of Fund (quarterly)    ACAD price (monthly, adj. close)

Other funds also holding ACAD

As of 2025 Q4 — sorted by position size

Palo Alto Investors LP 3Y 7Y 9.24% BAKER BROS. ADVISORS LP 3Y 7Y 6.71% Birchview Capital, LP 3Y 7Y 2.67% Nan Fung Group Holdings Ltd 3Y 2.46% Axecap Investments, LLC 2.25% Stonepine Capital Management, LLC 3Y 7Y 1.95% RTW INVESTMENTS, LP 3Y 7Y 1.91% BRAIDWELL LP 3Y 1.74% Logos Global Management LP 3Y 1.37% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.1%
← Back to OMERS ADMINISTRATION Corp Holdings